Novartis has provided updated data from phase 3 trials of ZOLGENSMA (onasemnogene abeparvovec-xioi) for patients with spinal muscular atrophy. …
Latest Video
New Stories
-
Pfizer Invites: ‘Life on the Other Side’
June 4, 2020 - - Latest News -
Maybe investigate the issue rather than just get rid of it?
June 4, 2020 - - Comment -
Medicines Australia has 'immediate concerns' over 'review and rescind'
June 4, 2020 - - Latest News -
'Project Orbis' review for STA lung cancer therapy
June 4, 2020 - - Latest News -
COVID-19: Investors call for action to protect life sciences
June 4, 2020 - - Latest News -
Chris Bowen slams 'arbitrary deadline' that will 'only worsen' access
June 3, 2020 - - Latest News -
The 'rescind' and 'inactivate' fix to a political problem
June 3, 2020 - - Comment